Research progress on quality evaluation of Salviae Miltiorrhizae Radix et Rhizoma(Danshen).
10.19540/j.cnki.cjcmm.20180109.004
- Author:
Wen-Tao FANG
1
;
Ai-Ping DENG
1
;
Zhen-Li REN
2
;
Tie-Gui NAN
1
;
Li-Ping KANG
1
;
Lan-Ping GUO
1
;
Lu-Qi HUANG
1
;
Zhi-Lai ZHAN
1
Author Information
1. State Key Laboratory Breeding Base of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
2. Shandong Danhong Pharmaceutical Co., Ltd., Heze 274000, China.
- Publication Type:Journal Article
- Keywords:
Salvia miltiorrhiza;
quality evaluation;
research progress
- From:
China Journal of Chinese Materia Medica
2018;43(6):1077-1085
- CountryChina
- Language:Chinese
-
Abstract:
Salviae Miltiorrhizae Radix et Rhizoma (Danshen) is one of the commonly used bulk medicinal materials in China. It is widely used in clinical practice, and has many pharmacological effects, such as antithrombotic，antibacterial，anti-inflammatory，anti-oxidative and immunomodulatory activities. The quality of Danshen determines the quality of the curative effect. The current wild resources of Danshen gradually decrease, the cultivation area is widely distributed, among them, Shandong, Sichuan, Anhui, Shanxi, Hebei, Henan and other provinces have large acreage for Danshen. However, germplasm, origin, cultivation, harvest, process and other factors have a certain impact on the active ingredients of Danshen, which lead to the quality of Danshen good and bad mixed. This paper is based on the systematic analysis of literature on quality evaluation of Danshen. To provide a new idea for the further research on the quality of Danshen, we summarized the main factors affecting the quality of Salvia miltiorrhiza that of germplasm, origin, cultivation, harvest, process, storage, product specifications and so on.
